BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2089885)

  • 1. Therapeutic effects of topical dexamethasone on experimental brain tumours and peritumoural brain oedema.
    Ikeda Y; Carson BS; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():163-4. PubMed ID: 2089885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxygen free radicals in the genesis of peritumoural brain oedema in experimental malignant brain tumours.
    Ikeda Y; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():142-4. PubMed ID: 1965270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticosteroid treatment of vasogenic oedema.
    Rommel T; Bodsch W
    Acta Neurochir Suppl (Wien); 1988; 43():145-8. PubMed ID: 3213642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human lipocortin I on brain oedema in a rat glioma model.
    Chang CC; Shinonaga M; Kuwabara T; Mima T; Shigeno T
    Acta Neurochir Suppl (Wien); 1990; 51():145-7. PubMed ID: 2151008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of changes in brain water in man by magnetic resonance imaging.
    Bell BA
    Ann R Coll Surg Engl; 1989 Nov; 71(6):375-80. PubMed ID: 2513767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of topical dexamethasone on experimental brain tumors and peritumoral brain edema.
    Ikeda Y; Carson BS; Long DM
    Acta Neurochir Suppl (Wien); 1994; 60():397-9. PubMed ID: 7976601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the arachidonate lipoxygenase inhibitor BW755C on traumatic and peritumoural brain oedema.
    Ikeda Y; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():68-70. PubMed ID: 2128585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction factors for gravimetric measurement of peritumoural oedema in man.
    Bell BA; Smith MA; Tocher JL; Miller JD
    Br J Neurosurg; 1987; 1(4):441-6. PubMed ID: 3268140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation and resolution of white matter oedema in various types of brain tumours.
    Ito U; Tomita H; Tone O; Shishido T; Hayashi H
    Acta Neurochir Suppl (Wien); 1990; 51():149-51. PubMed ID: 2089880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial delivery of dexamethasone in the brain for the reduction of peritumoral edema.
    Tamargo RJ; Sills AK; Reinhard CS; Pinn ML; Long DM; Brem H
    J Neurosurg; 1991 Jun; 74(6):956-61. PubMed ID: 2033457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer.
    Lewis KM; Harford-Wright E; Vink R; Ghabriel MN
    Anticancer Drugs; 2013 Apr; 24(4):344-54. PubMed ID: 23407059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid therapy of experimental tumour oedema.
    Matsuoka Y; Hossmann KA
    Neurosurg Rev; 1981; 4(4):185-90. PubMed ID: 7329560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose- and time-dependent effects of dexamethasone on rat brain following cold-injury oedema.
    Meinig G; Deisenroth K
    Acta Neurochir Suppl (Wien); 1990; 51():100-3. PubMed ID: 2089871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema.
    Ikeda Y; Carson BS; Lauer JA; Long DM
    J Neurosurg; 1993 Nov; 79(5):716-21. PubMed ID: 8410250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors affecting the extension of peritumoural brain oedema. A CT-study.
    Reulen HJ; Graber S; Huber P; Ito U
    Acta Neurochir (Wien); 1988; 95(1-2):19-24. PubMed ID: 3218550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase inhibits brain oedema formation in experimental pneumococcal meningitis.
    Pfister HW; Koedel U; Dirnagl U; Haberl RL; Feiden W; Einhäupl KM
    Acta Neurochir Suppl (Wien); 1990; 51():378-80. PubMed ID: 2089945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resorption of peritumoural oedema in cerebral gliomas during dexamethasone treatment evaluated by NMR relaxation time imaging.
    Andersen C; Haselgrove JC; Doenstrup S; Astrup J; Gyldensted C
    Acta Neurochir (Wien); 1993; 122(3-4):218-24. PubMed ID: 8372711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated macrophage-derived interleukin-1 mediates glioblastoma-associated cerebral oedema.
    Herting CJ; Chen Z; Maximov V; Duffy A; Szulzewsky F; Shayakhmetov DM; Hambardzumyan D
    Brain; 2019 Dec; 142(12):3834-3851. PubMed ID: 31665239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritumoural brain oedema in intracranial meningiomas: influence of tumour size, location and histology.
    Bitzer M; Wöckel L; Morgalla M; Keller C; Friese S; Heiss E; Meyermann R; Grote E; Voigt K
    Acta Neurochir (Wien); 1997; 139(12):1136-42. PubMed ID: 9479419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours.
    Lewis KM; Harford-Wright E; Vink R; Ghabriel MN
    J Neuroimmunol; 2012 Sep; 250(1-2):59-65. PubMed ID: 22722013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.